Africa Health Strategy

Clinical development

Design and management of clinical trials adapted to African contexts, particularly for tropical and infectious diseases (malaria, tuberculosis, etc.)

Strategic partnerships

Support in structuring study protocols in compliance with international regulations (ICH Guidelines, WHO).

Product development

Implementing methodological best practice: pragmatic, adaptive and community trials.

Working with key players to meet the specific needs of the African continent.

Expertise

Pharmacovigilance and product safety

Post-marketing surveillance and analysis of pharmacovigilance data.

Expertise

Identification and proactive management of risks relating to medicines and healthcare products.

Working with national and regional agencies to strengthen pharmacovigilance in countries with limited resources.

Medico-economic evaluation

Cost-effectiveness, cost-utility and budget impact analyses for drugs and medical devices.

Expertise

Development of tools to optimise drug prices while guaranteeing access for vulnerable populations.

Support to align strategies with local priorities and the Sustainable Development Goals (SDGs) in public health.

Regulatory and market access strategies

Support for obtaining Marketing Authorisation and integration into national health systems.

Expertise

Developing appropriate pricing structures and regulating costs in collaboration with local and regional authorities.

Managing the legal and regulatory aspects of importing and distributing in Africa.

Training and capacity building

Organisation of training courses on clinical trial methodology and economic evaluation for healthcare professionals and local teams.

Expertise

Clinical trials, analysis of real-life data and cohort studies, health economics, epidemiology and pharmacology.

Digital health solutions

Development of digital systems for data collection and analysis, in collaboration with technical institutions.

Expertise

Digital transformation.